Author:
O'Brien Travis J.,Kidd Robert S.,Richard Craig A.H.,Ha Ngoc-Han,Witcher Preston,Tran Linda V.,Barbour April,Tuck Matthew,McIntosh Samantha D.,Douglas Jacqueline N.,Harralson Arthur F.
Funder
National Collaboration On Aging
Professional Practice Plan
Subject
Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine
Reference30 articles.
1. Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin;Kamali;Clin Pharmacol Ther,2004
2. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients;Miao;Eur J Clin Pharmacol,2007
3. The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery;Tatarunas;J Heart Valve Dis,2012
4. Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose;Herman;Pharmacogenomics J,2005
5. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose;Takeuchi;PLoS Genet,2009
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献